Free Trial
NASDAQ:EXAS

Exact Sciences Q1 2025 Earnings Report

Exact Sciences logo
$45.64 +0.85 (+1.90%)
As of 04:00 PM Eastern

Exact Sciences EPS Results

Actual EPS
N/A
Consensus EPS
-$0.35
Beat/Miss
N/A
One Year Ago EPS
N/A

Exact Sciences Revenue Results

Actual Revenue
N/A
Expected Revenue
$688.58 million
Beat/Miss
N/A
YoY Revenue Growth
N/A

Exact Sciences Announcement Details

Quarter
Q1 2025
Time
After Market Closes
Conference Call Date
Thursday, May 1, 2025
Conference Call Time
5:00PM ET

Conference Call Resources

Exact Sciences Earnings Headlines

The next market Nvidia is positioned to dominate …
Robots — built by Nvidia. Forbes says this could be " a $24 trillion opportunity for investors." Huang said, "The ChatGPT moment for robotics is right around the corner." In fact, I believe these robots could impact 65 million Americans lives — this year. And one stock — currently priced around $7 — could be the biggest winner.
2 Reasons to Like EXAS (and 1 Not So Much)
See More Exact Sciences Headlines
Get Earnings Announcements in your inbox

Want to stay updated on the latest earnings announcements and upcoming reports for companies like Exact Sciences? Sign up for Earnings360's daily newsletter to receive timely earnings updates on Exact Sciences and other key companies, straight to your email.

About Exact Sciences

Exact Sciences (NASDAQ:EXAS) provides cancer screening and diagnostic test products in the United States and internationally. The company offers Cologuard, a non-invasive stool-based DNA screening test to detect DNA and hemoglobin biomarkers associated with colorectal cancer and pre-cancer. It also provides Oncotype DX Breast Recurrence Score Test; Oncotype DX Breast DCIS Score Test; Oncotype DX Colon Recurrence Score Test; OncoExTra Test for tumor profiling for patients with advanced, metastatic, refractory, relapsed, or recurrent cancer; and Covid-19 testing services. The company's pipeline products focus on enhancing the Cologuard test's performance characteristics and developing blood and other fluid-based tests. It has license agreements with MAYO Foundation for Medical Education and Research, and Johns Hopkins University. Exact Sciences Corporation was incorporated in 1995 and is headquartered in Madison, Wisconsin.

View Exact Sciences Profile

More Earnings Resources from MarketBeat